Search
                    Oregon Paid Clinical Trials
A listing of 1212  clinical trials  in Oregon  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1201 - 1212 of 1212
        
                Oregon is currently home to 1212 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Portland, Eugene, Medford and Clackamas. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    A Scaleable Video Coaching Intervention for Opioid-using Mothers
                                
            
            
        Recruiting
                            
            
                This study will adapt and evaluate a novel, innovative, and highly scalable parenting intervention that employs video coaching to target responsive parenting, Filming Interactions to Nurture Development (FIND), among women who have been referred to or are in treatment for opioid misuse/addiction.             
        
        
    Gender:
                ALL
            Ages:
                50 years and below
            Trial Updated:
                03/27/2023
            
            Locations: University of Oregon, Eugene, Oregon         
        
        
            Conditions: Child Behavior, Parent-Child Relations, Substance Use, Substance Abuse
        
            
        
    
                
                                    Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                02/08/2023
            
            Locations: Oregon Health & Science University, Portland, Oregon         
        
        
            Conditions: Cancer
        
            
        
    
                
                                    Pediatric Cervical Spine Clearance: A Multicenter Prospective Observational Study
                                
            
            
        Recruiting
                            
            
                A prospective multicenter observational study, led by Dr. Katie Russell of Intermountain Primary Children's Hospital, that will examine the sensitivity, specificity, negative, and positive predictive values of CT scan and plain films in diagnosing cervical spine injury that requires treatment. This study is funded by the Primary Children's Hospital foundation.             
        
        
    Gender:
                ALL
            Ages:
                Between 0 years and 17 years
            Trial Updated:
                11/01/2022
            
            Locations: Oregon Health and Science University, Portland, Oregon         
        
        
            Conditions: Cervical Spine Fracture
        
            
        
    
                
                                    Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to study the long term safety and effectiveness of an artificial iris prosthesis for the treatment of iris defects.             
        
        
    Gender:
                ALL
            Ages:
                3 years and above
            Trial Updated:
                10/21/2022
            
            Locations: Oregon Eye Associates, Eugene, Oregon         
        
        
            Conditions: Full Aniridia, Partial Aniridia
        
            
        
    
                
                                    CERENOVUS Neurothrombectomy Devices Registry
                                
            
            
        Recruiting
                            
            
                A post-market registry evaluating the EmboTrap® Revascularization Device and CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.             
        
        
    Gender:
                All
            Ages:
                18 years and above
            Trial Updated:
                10/19/2022
            
            Locations: Oregon Health & Science University, Portland, Oregon         
        
        
            Conditions: Cerebral Stroke
        
            
        
    
                
                                    Clinical and Genetic Analysis of ROP
                                
            
            
        Recruiting
                            
            
                Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel that this study will result in specific knowledge discovery about ROP, as well as general knowledge about how image-based data and genetic data can be combined to better understand clinical...  Read More             
        
        
    Gender:
                ALL
            Ages:
                1 year and below
            Trial Updated:
                04/18/2022
            
            Locations: Oregon Health & Science University, Portland, Oregon         
        
        
            Conditions: Retinopathy of Prematurity
        
            
        
    
                
                                    Pilot Study of BCAA on Sleep
                                
            
            
        Recruiting
                            
            
                Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experiment...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 89 years
            Trial Updated:
                04/04/2022
            
            Locations: VA Portland Health Care System, Portland, Oregon         
        
        
            Conditions: Sleep Disorder, Traumatic Brain Injury
        
            
        
    
                
                                    Improving Sleep, Sleep-related Outcomes, and Biomarkers in Veterans
                                
            
            
        Recruiting
                            
            
                The primary purpose of this project is to determine the effect of morning bright light therapy (MBLT) on sleep in Veterans with traumatic brain injury (TBI). Secondarily, the project aims to identify blood-based brain biomarkers (BBBM) associated with sleep in Veterans.
Specific Aim 1. Determine the effect of MBLT on sleep quality in Veterans (primary outcome).
Specific Aim 2. Determine the effect of MBLT on downstream effectors of improved sleep, including cognition, mood, and quality of life...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 88 years
            Trial Updated:
                04/04/2022
            
            Locations: Portland VA Medical Center, Portland, Oregon         
        
        
            Conditions: Traumatic Brain Injury
        
            
        
    
                
                                    Morning Bright Light to Improve Sleep Quality in Veterans
                                
            
            
        Recruiting
                            
            
                One of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a variety of conditions, but little has been done investigating the utility of MBLT in improving sleep in Veterans with TBI. This proposal aims to determine the effect of MBLT on sleep quality in Veterans with TBI. Vetera...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                04/04/2022
            
            Locations: VA Portland Health Care System, Portland, Oregon         
        
        
            Conditions: Brain Injuries, Traumatic, Post-traumatic Stress Disorder
        
            
        
    
                
                                    Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
                                
            
            
        Recruiting
                            
            
                The goal of this study is to determine the safety and tolerability or efficacy of adjunctive treatments (including rosuvastatin 20 mg daily) in combination with standard anticoagulation therapy (Factor Xa inhibitors) in patients with lower extremity deep vein thrombosis (DVT). The efficacy of adjunctive treatments to prevent the development of post thrombotic syndrome (PTS) after DVT will be evaluated.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 85 years
            Trial Updated:
                10/14/2021
            
            Locations: VA Portland Health Care System (VAPORHCS), Portland, Oregon         
        
        
            Conditions: Post-thrombotic Syndrome, Deep Vein Thrombosis Leg
        
            
        
    
                
                                    To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
                                
            
            
        Recruiting
                            
            
                The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.             
        
        
    Gender:
                All
            Ages:
                18 years and above
            Trial Updated:
                03/24/2021
            
            Locations: Kaiser Permanente - Northwest, Portland, Oregon         
        
        
            Conditions: Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis
        
            
        
    
                
                                    Augmentation of Limb Perfusion With Contrast Ultrasound
                                
            
            
        Recruiting
                            
            
                Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made in mice with and without peripheral artery disease (PAD), and also in humans where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was found also to augment perfusion by almost 2-fold. The latter human studies were performed with ultrasound protocols designed for per...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 19 years and 99 years
            Trial Updated:
                08/21/2018
            
            Locations: OHSU, Portland, Oregon         
        
        
            Conditions: Peripheral Arterial Disease
        
            
        
    